Logotipo do repositório

Sequels associated with breast cancer treatment: what is important to measure in a report

dc.contributor.authorVieira, René Aloisio da Costa
dc.contributor.authorCampos, Rhayssa Espósito Santos
dc.contributor.authorAmorim, Marcos Antônio
dc.contributor.authorSilveira, Antônio Dircio
dc.contributor.authorOliveira, Luiz Carlos Navarro de
dc.contributor.authorSarri, Almir José
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)pt
dc.date.accessioned2026-10-01T19:19:33Z
dc.date.issued2023-01-01
dc.description.abstractBreast cancer treatment is associated with functional sequelae that limit patients in their daily activities or work, impacting their quality of life. This fact becomes more noticeable in the Public System, the tumors are more advanced, leading to more aggressive treatments. Women with low education generally perform menial activities, playing an important role in family income. After cancer treatment, many are unable to carry out their usual activities, having difficulties with their work activities, requiring rehabilitation. These dysfunctions make it difficult or unfeasible to return to work, limiting family income. Knowledge of the Laws, the main sequelae and evaluation methodologies facilitates a more accurate diagnosis of functional conditions, determining the need for rehabilitation. Social Security provides economic support, but to have access to the benefit, a good report is necessary. This, well directed, helps the social security expert and the patients, who are generally so fragile by the disease and the treatment. In this article we discuss the main functional sequelae, how to evaluate them, and how to make a good report to be sent to an expert.
dc.description.affiliationFaculdade de Medicina de Botucatu, Brazil
dc.description.affiliationHospital de Câncer de Muriaé, Brazil
dc.description.affiliationHospital de Câncer de Barretos, Brazil
dc.description.affiliationUnespFaculdade de Medicina de Botucatu, Brazil
dc.identifierhttps://app.dimensions.ai/details/publication/pub.1159979879
dc.identifier.dimensionspub.1159979879
dc.identifier.doi10.29289/2594539420220050
dc.identifier.issn2594-5408
dc.identifier.issn2594-5394
dc.identifier.issn25945394
dc.identifier.lattes9872331461426316
dc.identifier.orcid0000-0003-4306-0356
dc.identifier.orcid0009-0005-7001-3469
dc.identifier.orcid0000-0001-6997-4231
dc.identifier.orcid0000-0003-1929-8591
dc.identifier.orcid0000-0001-9184-584X
dc.identifier.urihttps://hdl.handle.net/11449/332407
dc.publisherMastology
dc.relation.ispartofMastology; v. 33
dc.rights.accessRightsAcesso abertopt
dc.rights.sourceRightsoa_all
dc.rights.sourceRightshybrid
dc.sourceDimensions
dc.titleSequels associated with breast cancer treatment: what is important to measure in a report
dc.typeArtigopt
dspace.entity.typePublication
relation.isAuthorOfPublication72a1d1a2-ccb2-4987-854b-39306c4ae43f
relation.isAuthorOfPublication.latestForDiscovery72a1d1a2-ccb2-4987-854b-39306c4ae43f
relation.isOrgUnitOfPublicationa3cdb24b-db92-40d9-b3af-2eacecf9f2ba
relation.isOrgUnitOfPublication.latestForDiscoverya3cdb24b-db92-40d9-b3af-2eacecf9f2ba
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt

Arquivos

Pacote original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
MAS_2022050_AOP.pdf
Tamanho:
463,96 KB
Formato:
Adobe Portable Document Format